Join the Oncology Voice Network. Join for Free
The Importance of Networking for MSLs with Amy Misnik
MSL industry Hematology Oncology MSL networking Medical Science Liaison pharmaceutical career

The Importance of Networking for MSLs with Amy Misnik


Share This Article


Summary

Today I have Amy Misnik on the podcast. She is the Director, Medical Science Liaisons, Hematology Oncology at The Janssen Pharmaceutical Companies of Johnson & Johnson. Today she will be sharing about her role and you will be hearing our discussion about the importance of networking in the MSL industry.

Key Points

  • Getting into the industry
  • The MSL role
  • Transition from MSL to MSL management
  • Preparation for the transition
  • The importance of networking in industry for MSL
  • Examples of what people can do to help build their network
  • Tips for networking for job search
  • Outside of LinkedIn networking opportunities
  • Advice to give to aspiring MSLs looking to break into their first industry position
  • What qualities do you look for in MSLs?

This episode is sponsored by MSL Mastery, helping Medical Science Liaisons and aspiring MSLs to excel in their careers and lives through courses, coaching, and community. For more details, please visit MSLmastery.com.

The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel.

MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversations and medical affairs discussions.

Click for Source
MSL industry, Hematology Oncology, MSL networking, Medical Science Liaison, pharmaceutical career

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Explore OVN